Skip to content

A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients

A Pilot Study of Changing Medication Adherence In Hypertensive African-American Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00248937
Enrollment
40
Registered
2005-11-04
Start date
2004-02-29
Completion date
2004-06-30
Last updated
2008-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

African-American, Hypertension, Medication adherence, Risk reduction

Brief summary

We will conduct an empirical test of the two intervention approaches under study. Specifically, we seek to determine the potential differential impact of positive affect induction and self affirmation.

Detailed description

We are interested in achieving an empirical test of the two intervention approaches under study. Specifically, we seek to determine the potential differential impact of positive affect induction and self affirmation following the qualitative phase. 1. Positive affect induction: We will tests two types of positive affect induction. 1) sending patients a small gift, and 2) reminding patients of positive thoughts about themselves. Gift: Prior to a telephone call, patients in the positive affect condition will receive a small gift. Positive thoughts about themselves: Patients will be asked to describe a time when someone was helpful to them, and they felt good about it , and were nice to them in return. 2. Self affirmation: consists of a series of items reminding people of their core values. 3. Control: Control patients will have neither self affirmation nor gifts. Follow-up: At two weeks after enrollment all patients will be called to ascertain impact of the pilot intervention.

Interventions

BEHAVIORALPositive affect and self-affect induction

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients must be self-identified as African-Americans. 2. All patients must be aged 18 years and older. 3. All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure \> 140 mm hg or a diastolic blood pressure \> 90 mm hg or if participants are taking any prescribed antihypertensive medication. 4. Patients must be able to provide informed consent in English.

Exclusion criteria

1. Patients who are unable to walk several blocks for any reason. 2. Patients who refused to participate 3. Patients who are unable to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Within patient change on the Positive and Negative Affect Scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026